OncoRevive is developing a multiomics liquid biopsy kit to monitor treatment response, track cancer recurrence, and improve early detection. Our AI-powered platform analyses DNA, proteins, and glycoproteins with 300x higher accuracy, detecting even weak signals with >1-billionX signal enhancement. It profiles 30+ biomarkers in a single test, delivering same-day results at a cost 4X less than traditional methods. Unlike existing approaches, it's scalable, and requires no expert interpretation.